SCHEMBL315808

SCHEMBL315808

CCOc1cccc(Cl)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 1/20 0.59
CYP3A4 P08684 1/20 0.59
KMT2A Q03164 2/20 0.57
WDR5 P61964 1/20 0.55
LMNA P02545 1/20 0.53
MAPK1 P28482 1/20 0.53
HTT P42858 1/20 0.53
SMN1; SMN2 Q16637 1/20 0.53
KCNH2 Q12809 1/20 0.53
KDM4E B2RXH2 2/20 0.50
ALOX15 P16050 1/20 0.50
DRD2 P14416 1/20 0.50
DRD4 P21917 1/20 0.50
MEN1 O00255 1/20 0.50
FADS1 O60427 1/20 0.49
NQO1 P15559 1/20 0.48
MAOB P27338 1/20 0.47
AOC3 Q16853 1/20 0.47
RXRA P19793 1/20 0.47
RXRB P28702 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30167806 1.00 TP53 (0.59) TP53CYP3A4KMT2AWDR5LMNA
1,3-Diethoxybenzene SCHEMBL6565543 0.94 TP53 (0.57) TP53CYP3A4KMT2AWDR5LMNA
Acetaldehyde SCHEMBL27974152 0.89 KMT2A (0.53) TP53CYP3A4KMT2AWDR5LMNA
SCHEMBL24854715 0.84 KMT2A (0.51) TP53CYP3A4KMT2AWDR5LMNA
1,3-Diethoxybenzene SCHEMBL1100167 0.84 TP53 (0.71) TP53CYP3A4KMT2ALMNAMAPK1
SCHEMBL196962 0.83 KMT2A (0.68) TP53KMT2AWDR5LMNAMAPK1
SCHEMBL9808215 0.82 LMNA (0.67) KMT2AWDR5LMNAMAPK1HTT
SCHEMBL197632 0.82 KMT2A (0.76) KMT2ALMNAMAPK1HTTSMN1; SMN2
SCHEMBL8551026 0.80 KMT2A (0.73) KMT2ALMNAMAPK1HTTSMN1; SMN2
SCHEMBL11833932 0.80 WDR5 (0.56) KMT2AWDR5LMNAMAPK1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 173 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9169209-B2 Compounds and compositions for the inhibition of NAMPT FORMA TM, LLC (US) 2015-10-27 US claimed
US-20140275057-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT Valo Health, LLC 2014-09-18 US claimed
WO-2012150952-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT FORMA TM, LLC (US) 2012-11-08 WO claimed
EP-0790251-B1 Preparation and use of (3-alkoxyphenyl) magnesium chlorides GRUENENTHAL GMBH (DE) 2002-12-04 EP claimed
CN-1075075-C Preparation and use of (3-alkoxyphenyl) magnesium chlorides GRUENETHAL GMBH (DE) 2001-11-21 CN claimed
CN-1166491-A Preparation and use of (3-alkoxyphenyl) magnesium chlorides GRUENENTHAL GMBH (DE) 1997-12-03 CN claimed
EP-0790251-A2 Preparation and use of (3-alkoxyphenyl) magnesium chlorides Grünenthal GmbH (DE) 1997-08-20 EP claimed
US-4473713-A Hydrolysis of aryl-aliphatic ethers RHONE-POULENC SPECIALITES CHIMIQUES (FR) 1984-09-25 US claimed
US-12336981-B2 Compounds and compositions for the inhibition of NAMPT VALO HEALTH, INC. (US) 2025-06-24 US disclosed
EP-3632892-B1 METHOD FOR PRODUCING 3-ARYLPROPIONAMIDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2024-07-31 EP disclosed
US-20230346753-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT VALO HEALTH, INC. 2023-11-02 US disclosed
US-20230337672-A1 METHOD OF CONTROLLING SOYBEAN RUST FUNGUS HAVING RESISTANCE TO QoI FUNGICIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-10-26 US disclosed
US-20230337672-A1 METHOD OF CONTROLLING SOYBEAN RUST FUNGUS HAVING RESISTANCE TO QoI FUNGICIDE SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-10-26 US disclosed
US-20230232827-A1 METHOD FOR CONTROLLING SOYBEAN RUST FUNGUS RESISTANT TO QoI FUNGICIDES SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2023-07-27 US disclosed
US-4001301-A ANTIINFLAMMATORY AGENTS, ANALGESICS, ANTIPYRETICS, ANTI-PRURITIC SYNTEX CORPORATION (PM) 1977-01-04 US disclosed
US-3998966-A Anti-inflammatory, analgesic, anti-pyretic and anti-pruritic 6-substituted 2-naphthyl acetic acid derivative-containing compositions and methods of use thereof SYNTEX CORPORATION (PM) 1976-12-21 US disclosed
US-3980699-A ANTIINFLAMMATORY, ANALGESICS, ANTIPYRETIC, ANTIPRURITIC SYNTEX CORPORATION (PM) 1976-09-14 US disclosed
US-3978124-A ANALGESIC, ANTIPYRETIC SYNTEX CORPORATION (PM) 1976-08-31 US disclosed
US-3978116-A ANALGESIC, ANTIPYRETIC SYNTEX CORPORATION (PM) 1976-08-31 US disclosed
US-3956407-A REACTING AN OLEFIN COMPOUND WITH FORMALDEHYDE, CATALYST PHILLIPS PETROLEUM COMPANY (US) 1976-05-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12336981-B2 Compounds and compositions for the inhibition of NAMPT NAMPT, NNMT, NNT TP53 4867/4885CYP3A4 1187/4885KMT2A 912/4885
US-20140275057-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT NAMPT, NNMT, NAPRT TP53 4878/4885CYP3A4 1790/4885KMT2A 1479/4885
US-20230337672-A1 METHOD OF CONTROLLING SOYBEAN RUST FUNGUS HAVING RESISTANCE TO QoI FUNGICIDE CYC1, SQOR, MT-CO1 TP53 3345/4885CYP3A4 331/4885KMT2A 2458/4885
US-20230346753-A1 NOVEL COMPOUNDS AND COMPOSITIONS FOR THE INHIBITION OF NAMPT NAMPT, NNMT, NQO1 TP53 4877/4885CYP3A4 2444/4885KMT2A 1615/4885
US-20230232827-A1 METHOD FOR CONTROLLING SOYBEAN RUST FUNGUS RESISTANT TO QoI FUNGICIDES CYC1, SQOR, MT-CO3 TP53 2943/4885CYP3A4 350/4885KMT2A 2852/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.